Brain-computer interface (BCI) concept stocks rallied collectively during early trading today. The surge follows a major breakthrough in China's BCI sector, enabling paralyzed patients to control wheelchairs and robotic dogs via thought.
On December 17, the Chinese Academy of Sciences' Center for Excellence in Brain Science and Intelligence Technology announced groundbreaking progress in invasive BCI systems. Using a high-throughput wireless invasive BCI system (WRS01), researchers successfully allowed a quadriplegic patient to steadily operate smart wheelchairs and robotic dogs through brain signals, achieving autonomous movement and object retrieval in real-life scenarios.
Key technological advancements include: - 15%-20% improvement in overall brain-control performance through effective signal extraction in noisy environments - Overcoming signal instability caused by environmental interference (acoustic, optical, electromagnetic) and patient physiological/psychological fluctuations - Reducing end-to-end system latency (signal acquisition to command execution) below 100ms through custom protocols—faster than the human nervous system's natural 200ms transmission delay
Market data shows China's BCI market reached RMB 3.2 billion in 2024, projected to hit RMB 6.14 billion by 2028. Globally, Precedence Research estimates the BCI market will grow from $2.62 billion in 2024 to $2.94 billion in 2025, potentially reaching $12.4 billion by 2034—a 17.35% CAGR over a decade.
Analyst perspectives: - Southwest Securities: Policy support and technological innovation create significant potential for China's BCI industry - Guotai Haitong: Multiple drivers (tech breakthroughs, policy guidance, capital investment) may accelerate BCI adoption in healthcare and consumer applications
Key concept stocks: 1. Innovative Medical Management Co.,Ltd. (002173.SZ): Holds 40% stake in BoLing Medical, developing China's only Phase III clinical invasive BCI system (BCI-4000), comparable to Neuralink 2. Iflytek Co.,Ltd. (002230.SZ): Leverages AI expertise for BCI medical applications through university collaborations 3. LENOVO GROUP (00992): Launched "Lenovo Mind X1"—the world's first consumer-grade BCI headset with 85%+ accuracy for 12-15 words/minute thought input 4. Sanbo Hospital Management Group Limited (301293.SZ): Completed China's first interventional BCI trial using minimally invasive vascular surgery for stroke/paralysis treatment 5. Wuhan Guide Infrared Co.,Ltd. (002414.SZ): Subsidiary developed a 65,000-channel implantable chip with 20x Neuralink's channel density, bypassing U.S. patent restrictions 6. Zhejiang Jinke Tom Culture Industry Co.,Ltd. (300459.SZ): Exploring "AI+neuroscience" models for children's education/rehabilitation 7. Hanwei Electronics Group Corporation (300007.SZ): Subsidiary develops flexible electrodes and EEG signal acquisition technologies with commercialization potential